| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.072 | 0.02 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.078 | 0.02 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.02 |
| mRNA | NU-7441 | GDSC1000 | pan-cancer | AAC | -0.084 | 0.02 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | -0.08 | 0.02 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.073 | 0.02 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | 0.079 | 0.02 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | 0.085 | 0.02 |
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | -0.077 | 0.02 |